A study from Karolinska Institutet and Queen Mary University of London published in PLOS Medicine suggests HPV self-tests can divide HPV-positive women into three risk groups, enhancing cervical cancer screening. The study, conducted in England, found 8.3% of 855 women with positive HPV self-tests had severe cervical precancer or cancer. Risk stratification, based on HPV type and virus amount, identified high-risk women needing immediate colposcopy, while low-risk women could be retested after 12 months. This method could benefit cervical cancer screening in resource-limited settings.